PHS
PFM Health Sciences Portfolio holdings
AUM
$1.15B
This Quarter Return
-9.66%
1 Year Return
+21.39%
3 Year Return
+130.75%
5 Year Return
+265.32%
10 Year Return
+1,236.5%
AUM
$1.21B
AUM Growth
+$1.21B
(-30%)
Cap. Flow
-$387M
Cap. Flow
% of AUM
-31.95%
Top 10 Holdings %
Top 10 Hldgs %
37.67%
Holding
84
New
25
Increased
14
Reduced
19
Closed
21
Top Buys
| 1 |
McKesson
MCK
|
$46.5M |
| 2 |
AbbVie
ABBV
|
$42.5M |
| 3 |
Cardinal Health
CAH
|
$42.1M |
| 4 |
Becton Dickinson
BDX
|
$34.7M |
| 5 |
Cencora
COR
|
$30M |
Top Sells
| 1 |
BOLD
Audentes Therapeutics, Inc
BOLD
|
$73.8M |
| 2 |
NVRO
NEVRO CORP.
NVRO
|
$67.8M |
| 3 |
Zimmer Biomet
ZBH
|
$66.3M |
| 4 |
Gilead Sciences
GILD
|
$59.7M |
| 5 |
AGN
Allergan plc
AGN
|
$53.8M |
Sector Composition
| 1 | Healthcare | 84.85% |
| 2 | Technology | 3.15% |
| 3 | Consumer Discretionary | 1.98% |
| 4 | Industrials | 0.46% |
| 5 | Utilities | 0.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Centene
CNC
$14.8B
| $18.3M | 1.5% |
307,441
-511,788
| -62% | -$30.4M |
|
27
Molina Healthcare
MOH
$9.6B
| $17.4M | 1.43% |
124,444
-52,520
| -30% | -$7.34M |
|
28
IQVIA
IQV
$31.4B
| $17M | 1.39% |
157,201
-186,366
| -54% | -$20.1M |
|
29
HCA Healthcare
HCA
$95.4B
| $16.7M | 1.37% |
185,849
-93,562
| -33% | -$8.41M |
|
30
NVIDIA
NVDA
$4.15T
| $16.3M | 1.34% |
61,842
+21,953
| +55% | +$5.79M |
|
31
Microsoft
MSFT
$3.76T
| $15M | 1.23% |
95,177
+23,810
| +33% | +$3.75M |
|
|
IMMU
32
DELISTED
Immunomedics Inc
IMMU
| $14.3M | 1.18% |
1,064,041
-435,198
| -29% | -$5.87M |
|
|
RETA
33
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $14.1M | 1.16% |
+97,864
| New | +$14.1M |
|
34
Alibaba
BABA
$325B
| $13.6M | 1.12% |
70,083
+25,672
| +58% | +$4.99M |
|
35
Icon
ICLR
$14B
| $12.6M | 1.03% |
92,446
-101,131
| -52% | -$13.8M |
|
|
SAGE
36
DELISTED
Sage Therapeutics
SAGE
| $12.5M | 1.03% |
+436,477
| New | +$12.5M |
|
37
Arcus Biosciences
RCUS
$1.24B
| $11.2M | 0.92% |
+809,511
| New | +$11.2M |
|
38
Halozyme
HALO
$8.75B
| $11.1M | 0.91% |
618,726
+25,246
| +4% | +$454K |
|
39
Amazon
AMZN
$2.41T
| $10.4M | 0.86% |
+5,342
| New | +$10.4M |
|
|
CNST
40
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
| $9.93M | 0.82% |
+315,894
| New | +$9.93M |
|
|
XLNX
41
DELISTED
Xilinx Inc
XLNX
| $9.72M | 0.8% |
+124,677
| New | +$9.72M |
|
|
IGMS
42
DELISTED
IGM Biosciences
IGMS
| $9.16M | 0.75% |
+163,105
| New | +$9.16M |
|
43
Alnylam Pharmaceuticals
ALNY
$58.6B
| $8.9M | 0.73% |
+81,804
| New | +$8.9M |
|
|
PPD
44
DELISTED
PPD, Inc. Common Stock
PPD
| $8.51M | 0.7% |
+477,743
| New | +$8.51M |
|
|
DCPH
45
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $8.5M | 0.7% |
+206,336
| New | +$8.5M |
|
46
Coherus Oncology, Inc. Common Stock
CHRS
$146M
| $7.69M | 0.63% |
474,055
-61,031
| -11% | -$990K |
|
47
Standard BioTools
LAB
$493M
| $6.79M | 0.56% |
2,673,090
-561,894
| -17% | -$1.43M |
|
48
Deere & Co
DE
$127B
| $5.56M | 0.46% |
+40,208
| New | +$5.56M |
|
|
XLRN
49
DELISTED
Acceleron Pharma Inc.
XLRN
| $5.52M | 0.45% |
+61,400
| New | +$5.52M |
|
50
Zai Lab
ZLAB
$3.48B
| $4.34M | 0.36% |
+84,387
| New | +$4.34M |
|